100 related articles for article (PubMed ID: 17956259)
1. Picking pockets to fuel antimicrobial drug discovery.
Hunter WN
Biochem Soc Trans; 2007 Nov; 35(Pt 5):980-4. PubMed ID: 17956259
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design of anti-infectives.
Agarwal AK; Fishwick CW
Ann N Y Acad Sci; 2010 Dec; 1213():20-45. PubMed ID: 21175675
[TBL] [Abstract][Full Text] [Related]
3. Structure-based drug design: exploring the proper filling of apolar pockets at enzyme active sites.
Zürcher M; Diederich F
J Org Chem; 2008 Jun; 73(12):4345-61. PubMed ID: 18510366
[TBL] [Abstract][Full Text] [Related]
4. New targets and screening approaches in antimicrobial drug discovery.
Brown ED; Wright GD
Chem Rev; 2005 Feb; 105(2):759-74. PubMed ID: 15700964
[No Abstract] [Full Text] [Related]
5. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and docking studies of new furobenzopyranones and pyranobenzopyranones as photoreagent towards DNA and as antimicrobial agents.
Farag NA; El-Tayeb W
Eur J Med Chem; 2010 Jan; 45(1):317-25. PubMed ID: 19897282
[TBL] [Abstract][Full Text] [Related]
7. Isoprenoid biosynthetic pathways as anti-infective drug targets.
Rohdich F; Bacher A; Eisenreich W
Biochem Soc Trans; 2005 Aug; 33(Pt 4):785-91. PubMed ID: 16042599
[TBL] [Abstract][Full Text] [Related]
8. Folate biosynthesis pathway: mechanisms and insights into drug design for infectious diseases.
Bertacine Dias MV; Santos JC; Libreros-Zúñiga GA; Ribeiro JA; Chavez-Pacheco SM
Future Med Chem; 2018 Apr; 10(8):935-959. PubMed ID: 29629843
[TBL] [Abstract][Full Text] [Related]
9. [The possibility of drug design of quinolones effective for multiresistant gram-positive pathogens].
Hayakawa I
Nihon Rinsho; 1997 May; 55(5):1266-71. PubMed ID: 9155185
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of bacterial cystathionine beta-lyase: leads for new antimicrobial agents and probes of enzyme structure and function.
Ejim LJ; Blanchard JE; Koteva KP; Sumerfield R; Elowe NH; Chechetto JD; Brown ED; Junop MS; Wright GD
J Med Chem; 2007 Feb; 50(4):755-64. PubMed ID: 17300162
[TBL] [Abstract][Full Text] [Related]
11. Structural biology in fragment-based drug design.
Murray CW; Blundell TL
Curr Opin Struct Biol; 2010 Aug; 20(4):497-507. PubMed ID: 20471246
[TBL] [Abstract][Full Text] [Related]
12. Optimizing antimicrobial host defense peptides.
Sahl HG
Chem Biol; 2006 Oct; 13(10):1015-7. PubMed ID: 17052605
[TBL] [Abstract][Full Text] [Related]
13. Discovery of new Gram-negative antivirulence drugs: structure and properties of novel E. coli WaaC inhibitors.
Moreau F; Desroy N; Genevard JM; Vongsouthi V; Gerusz V; Le Fralliec G; Oliveira C; Floquet S; Denis A; Escaich S; Wolf K; Busemann M; Aschenbrenner A
Bioorg Med Chem Lett; 2008 Jul; 18(14):4022-6. PubMed ID: 18571407
[TBL] [Abstract][Full Text] [Related]
14. Beta-hairpin peptidomimetics: design, structures and biological activities.
Robinson JA
Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
[TBL] [Abstract][Full Text] [Related]
15. Bioconverted products of essential fatty acids as potential antimicrobial agents.
Bajpai VK; Kim HR; Hou CT; Kang SC
N Biotechnol; 2009 Oct; 26(3-4):122-30. PubMed ID: 19643210
[TBL] [Abstract][Full Text] [Related]
16. Methods for building quantitative structure-activity relationship (QSAR) descriptors and predictive models for computer-aided design of antimicrobial peptides.
Taboureau O
Methods Mol Biol; 2010; 618():77-86. PubMed ID: 20094859
[TBL] [Abstract][Full Text] [Related]
17. Druggability of the enzymes of the non-mevalonate-pathway.
Masini T; Kroezen BS; Hirsch AK
Drug Discov Today; 2013 Dec; 18(23-24):1256-62. PubMed ID: 23856326
[TBL] [Abstract][Full Text] [Related]
18. Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae.
Luo QL; Li JY; Liu ZY; Chen LL; Li J; Qian Z; Shen Q; Li Y; Lushington GH; Ye QZ; Nan FJ
J Med Chem; 2003 Jun; 46(13):2631-40. PubMed ID: 12801227
[TBL] [Abstract][Full Text] [Related]
19. Biofilm inhibition and antimicrobial action of lipopeptide biosurfactant produced by heavy metal tolerant strain Bacillus cereus NK1.
Sriram MI; Kalishwaralal K; Deepak V; Gracerosepat R; Srisakthi K; Gurunathan S
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):174-81. PubMed ID: 21458961
[TBL] [Abstract][Full Text] [Related]
20. Discovery and SAR of benzyl phenyl ethers as inhibitors of bacterial phenylalanyl-tRNA synthetase.
Montgomery JI; Toogood PL; Hutchings KM; Liu J; Narasimhan L; Braden T; Dermyer MR; Kulynych AD; Smith YD; Warmus JS; Taylor C
Bioorg Med Chem Lett; 2009 Feb; 19(3):665-9. PubMed ID: 19121937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
